Single-agent paclitaxel in patients with previously untreated stage IV epithelial ovarian cancer. London Gynaecological Oncology and North Thames Gynaecological Oncology Groups.

The aim of this study was to evaluate the efficacy of high-dose paclitaxel in patients with previously untreated stage IV epithelial ovarian cancer. Paclitaxel was administered intravenously over 3 h at a dose of 225 mg m(-2) on a 21-day cycle for six courses. Thirty-six patients were entered into t...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Gore, M. E., Rustin, G., Slevin, M., Gallagher, C., Penson, R., Osborne, R., Ledermann, J., Cameron, T., Thompson, J. M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group|1 1997
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2063326/
https://ncbi.nlm.nih.gov/pubmed/9043029
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia